Roivant Sciences Ltd.
Roivant Sciences Ltd.
Your view on ROIVW
Overview
What the company does, where it operates, and who runs it.
About Roivant Sciences Ltd.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Matthew Gline
- Headquarters
- 11-12 St. James’s Square, London, GB
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Matthew Gline
- Headquarters
- 11-12 St. James’s Square, London, GB
Roivant Sciences Ltd. operates as a biopharmaceutical and healthcare technology enterprise, concentrating on the research and development of innovative pharmaceutical solutions. The firm's pipeline features investigational therapies aimed at a diverse range of diseases. These include various oncologic malignancies (such as solid tumors), blood conditions like sickle cell disease, rare genetic disorders such as hypophosphatasia, and a spectrum of dermatological ailments including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, and acne. Additionally, their work extends to autoimmune disorders like myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, and sarcoidosis, alongside bacterial infections such as Staph aureus bacteremia. Founded in 2014, the company maintains its headquarters in London, United Kingdom.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Roivant Sciences Ltd., and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Roivant Sciences Ltd.. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Roivant Sciences Ltd.. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Roivant Sciences Ltd.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Roivant Sciences Ltd.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Roivant Sciences Ltd. valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Roivant Sciences Ltd., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Roivant Sciences Ltd. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Roivant Sciences Ltd.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Roivant Sciences Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Roivant Sciences Ltd.. Press releases and market coverage, newest first.